載入...
Trypsin inhibitors: promising candidate satietogenic proteins as complementary treatment for obesity and metabolic disorders?
The increase in non-communicable chronic diseases has aroused interest in the research of adjuvants to the classic forms of treatments. Obesity and metabolic syndrome are the main targets of confrontation because they relate directly to other chronic diseases. In this context, trypsin inhibitors, mo...
Na minha lista:
| 發表在: | J Enzyme Inhib Med Chem |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327991/ https://ncbi.nlm.nih.gov/pubmed/30734596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2018.1542387 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|